Back
Lucid Diagnostics, Inc. 10K Form
Sell
6
LUCD
Lucid Diagnostics, Inc.
Last Price:
$1.07
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LUCD News And Ratings
See the #1 stock for the next 7 days that we like better than LUCD
LUCD Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3M |
|---|---|
| Cash Flow: | $-10.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.22 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.89700 |
|---|---|
| Net Income (TTM): | $-53.3M |
| Gross Margin: | $-3.9M |
| Return on Equity: | -665.25% |
| Return on Assets: | -149.7% |
Lucid Diagnostics, Inc. Earnings Forecast
Key Lucid Diagnostics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for LUCD is -90.20%.
-
The Selling, General & Administrative Expenses for LUCD have been equal to 842.59% of Gross Profit Margin.
-
The Research & Development expenses have been 137.87% of Revenue.
-
The Net Earning history of LUCD is -1,047.61% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Lucid Diagnostics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LUCD |
| Website: | luciddx.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 1.9 |
| Quick Ratio: | 1.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LUCD Technical Analysis vs Fundamental Analysis
Sell
6
Lucid Diagnostics, Inc. (LUCD)
is a Sell
Is Lucid Diagnostics, Inc. a Buy or a Sell?
-
Lucid Diagnostics, Inc. stock is rated a SellThe current Lucid Diagnostics, Inc. [LUCD] share price is $1.06. The Score for LUCD is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.